Abstract
Bacterial meningitis is defined as the inflammation of both leptomeninges and the cerebrospinal fluid (CSF) that they contain, when caused by bacterial organisms. As a rule, the infectious process also affects the ependymus and ventricular CSF [1]. The most frequent bacterial meningitis are those due to pyogenic organisms that usually cause the typical clinical picture of acute meningitis with purulent CSF. The purulent aspect of the CSF is due to both bacterial growth and an intense polymorphonuclear response. Other bacterial agents, such as Brucella melitensis, Mycobacterium tuberculosis, Treponema pallidum, Leptospira sp and Borrelia burgdorferi, can also cause meningitis that often runs a subacute or chronic course and presents with clear CSF showing a predominantly lymphocytic pleocytosis. These agents will not be considered in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tunkel AR, Scheld WM. Acute meningitis. In Mandell GL, Bennett JE, Dolin R (eds). Principles and practice of infectious diseases, 4th edn, New York: Churchill Livingstone, 1994:831.
Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328:21, 1993.
Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 337:970, 1995.
Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 162:1316, 1986.
Adams WG, Deaver KE, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in Hib vaccine era. JAMA 269:221, 1993.
Liptak GS, McConnochie KM, Roghmann KJ, Panzer JA. Decline of pediatric admissions with Haemophilus influenzae type b in New York State, 1982 through 1993: relation to immunizations. J Pediatr 130:923, 1997.
Kaufman BA, Tunkel AR, Pryor JC, Dacey RG Jr. Meningitis in the neurosurgical patient. Infect Dis Clin North Am 4:677, 1990.
Ostabal MI, Suarez Pinilla MA, Sanz Sebastian C, Millastre A. Epidemiological study of nosocomial meningitis. Rev Neurol 24:265, 1996.
Pottecher T, Balabaud-Pichon V. Meningites nosocomiales de l’adulte. Ann Franc Anesth Rean 18:558, 1999.
Núñez ML, Martinez-Toldos MC, Bru M, Simarro E, Segovia M, Ruiz J. Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter. Scand J Infect Dis 30:421, 1998.
Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 131:543, 1975.
Kaufman BA, McLone DG. Infections of cerebrospinal fluid shunts. In Scheid WM, Whitley RJ, Durack DT (eds). Infections of the central nervous system. New York: Raven Press, 1991:561.
Ferré C, Ariza J, Viladrich PF, et al. Brain abscess rupturing into the ventricles or subarachnoid space. Am J Med 106:254, 1999.
Saez-Llorens X, et al. Molecular pathophysiology of bacterial meningitis: Current concepts and therapeutic implications. J Pediatr 116:671, 1990.
Quagliarello V, Scheid WM. Bacterial meningitis: Pathogenesis, pathophysiology, and progress. N Engl J Med 327:864, 1992.
Pfister HW, Fontana A, Täuber MG, Tomasz A, Sheld WM. Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin Infect Dis 19:463, 1994.
Viladrich PF. Enfermedad meningocócica en adolescentes y adultos (Hospital de Bellvitge, 1977–1990). Doctoral Thesis. Universidad de Barcelona, 1993.
Casado Flores J, García Teresa MA, Cambra F, et al. Estudio prospectivo multicéntrico de la meningitis bacteriana grave pediátrica. Ann Esp Pediatr 47:466, 1997.
Lacroix J, Deal C, Gauthier M, Rousseau E, Farrell FA. Admissions to a pediatric intensive care unit for status epilepticus: a 10-year experience. Crit Care Med 22:827, 1994.
Viladrich PF, Buenaventura I, Gudiol F, et al. Meningitis neumocócica del adulto. Estudio de 141 episodios. Med Clin (Barc) 87:569, 1986.
Pfister HW, Felden W, Einhäupl KM. Spectrum of complications during bacterial meningitis in adults. Arch Neurol 50:575, 1993.
Viladrich PF, Gudiol F. Avances en las infecciones del sistema nervioso central producidas por bacterias grampositivas. Rev Clin Esp 194:847, 1994.
Carpenter RR, Petersdorf RG. The clinical spectrum of bacterial meningitis. Am J Med 33:262, 1962.
Banks HS. Meningococcosis: a protean disease. Lancet ii:635 and 677, 1948.
Brandtzaeg P. Pathogenesis of meningococcal infections. In Cartwright K (ed). Meningococcal disease. Chichester: John Wiley, 1995:71.
Viladrich PF, Gudiol F, Run G, et al. Meningitis bacteriana. Etiologia y focos de origen de 482 episodios. Med Clin (Barc) 86:615, 1986.
Ariza J, Casanova A, Viladrich PF, et al. Etiological agent and primary source of infection in 42 cases of focal intracranial suppuration. J Clin Microbiol 24:899, 1986.
Sánchez C, Garau J, Viladrich PF, Nogueras A, Liñares J. La listeriosis del adulto: epidemiología, elínica, pronóstico y tratamiento. Med Clin (Barc) 84:533, 1985.
Fredricks DN, Relman DA. Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin Infect Dis 29:475, 1999.
Coant PN, Kornberg AE, Duffy C, Dryja DM, Hassan SM. Blood culture results as determinants in the organism identification of bacterial meningitis. Pediatr Emerg Care 8:200, 1992.
Milhaud D, Bernardin G, Rastello M, Mattei M, Blard JM. Meningites bacteriennes de l’adulte en reanimation médicale. Analyse clinique et etude des facteurs pronostiques. Press Med 25:353, 1996.
Horwitz SJ, Boxerbaum B, O’Bell J. Cerebral herniation in bacterial meningitis in childhood. Ann Neurol 7:524, 1980.
McDonald JT, Uden DL. Intravenous glycerol and mannitol therapy in children with intracranial hypertension. Neurology 32:437, 1982.
Coyle PK. Glucocorticoids in central nervous system bacterial infection. Arch Neurol 56:796, 1999.
Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 324:1525, 1991.
Mclntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278:925, 1997.
Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 8:848, 1989.
Quagliarello VJ, Scheid WM. Treatment of bacterial meningitis. N Engl J Med 336:708, 1997.
Almirante B, Cortés E, Pigrau C, et al. Terapeútica y evolueión de la meningitis neumocócica del adulto. Estudio de una serie reciente de 70 episodios. Med Clin (Barc) 105:681, 1995.
Alvarez-Lerma F, Cisneros JM, Viladrich PF, et al. Indications for admission to the intensive care service of adult patients with severe infections. Enf Infecc Microbiol Clin 16:423, 1998.
Sáez-Nieto JA, Vázquez JA, Marcos C. Meningococci moderately resistant to penicillin. Lancet 336:54, 1990.
Galimand M, Gerbaud G, Guibourdenche M, Riou JY, Courvalin P. High-level chloramphenicol resistance in Neisseria meningitidis. Lancet 339:868, 1998.
Pérez Trallero E, García Arenzana JM, Ayestarán Y, Muñoz Baroja I. Comparative activity in vitro of 16 antimicrobial agents against penicillin-susceptible meningococci and meningococci with diminished susceptibility to penicillin. Antimicrob Agents Chemother 33:1622, 1989.
Viladrich PF, Pallarés R, Ariza J, Rufi G, Gudiol F. Four days of penicillin therapy for meningococcal meningitis. Arch Intern Med 146:2380, 1988.
Viladrich PF. Las meningitis meningocócicas. Neurología 12:181, 1997.
Viladrich PF. Tratamiento y evolueión de la meningitis causada por neumococos resistentes a la penicilina. Rev Clin Esp 196, monográfico 2:9, 1996.
Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 35:2467, 1991.
Friedland IR, Klugman KP. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime. Antimicrob Agents Chemother 41: 1888, 1997.
Viladrich PF, Cabellos C, Pallarés R, et al. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother 40:218, 1996.
Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 39:1989, 1995.
Viladrich PF, Cabellos C, Martos A, Martinez Lacasa JT, Gudiol F. Lack of efficacy of pneumococcal vaccine in preventing pneumococcal meningitis due to cerebrospinal fluid leaks. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), October 1992, Anaheim, California, USA. (Abstract no. 1282).
Cherubin CE, Appleman MD, Heseltine PNR, et al. Epidemiologic spectrum and current treatment of listeriosis. Rev Infect Dis 13:1108,1991.
Cabellos C, Viladrich PF, Corredoira J, Verdaguer R, Ariza J, Gudiol F. Streptococcal meningitis in adult patients: current epidemiology and clinical spectrum. Clin Infect Dis 28:1104, 1999.
Alcaide F, Liñares J, Pallarés R, et al. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 39:2243, 1995.
Fernández Viladrich P. Papel de meropenem en la meningitis bacteriana. Enf Infecc Microbiol Clin 15 (Suppl):5761, 1997.
Viladrich PF, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenen-resistant Acinetobacter baumannii with intraventricular Colistin sulfomethate sodium. Clin Infect Dis 28:916, 1999.
Levin AS, Barone AA, Penço J, et al. Intravenous Colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008, 1999.
Frasch CE. Meningococal vaccines: Past, present and future. In Cartwright K (ed). Meningococcal disease. Chichester: John Wiley, 1995:245.
Korinek AM. Risk factors for neurosurgical site infections after craniotomy: a prospective multi-center study of 2944 patients. Neurosurgery 41:1073, 1997.
Viladrich PF, Tubau F, Cabellos C, et al. Vancomycin plus rifampin for therapy of adult pneumococcal meningitis. Clin Microbiol Infect 5 (suppl 3):250: (abstract no. P6l6), 1999.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Viladrich, P.F. (2001). Acute Bacterial Meningitis. In: Rello, J., Valles, J., Kollef, M.H. (eds) Critical Care Infectious Diseases Textbook. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1679-8_24
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1679-8_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5674-5
Online ISBN: 978-1-4615-1679-8
eBook Packages: Springer Book Archive